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Abstract
A series of novel spin-labeled 4β-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxin derivatives 
(17a–h) were firstly designed and synthesized with significant regioselectivity by employing Cu(I) 
catalyzed click approach, and evaluated for cytotoxicity against four human tumor cell lines 
(A-549, DU145, KB, and KBvin). Among them, compound 17h displayed the highest cytotoxic 
activity against the tumor cell lines tested. Significantly, compound 17h showed superior 
cytotoxic activity compared with etoposide (IC50 6.30 to>10 μM), a clinically available anticancer 
drug. Significant activity toward the drug resistant KBvin cell line revealed promising future for 
compound 17h as a new generation of epipodophyllotoxin-derived antitumor clinical trial 
candidate.
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Introduction
Podophyllotoxin (1, PPT), a naturally occurring aryltetralin lignan, has been used as a lead 
compound in the development of new potent anticancer drugs (Garcia and Azambuja, 2004). 
Its powerful cytotoxic properties have been attributed by its binding to tubulin during 
mitosis and thus inhibiting microtubule assembly (Jardine, 1980). The extensive chemical 
modifications of 1 led to two anticancer drugs, etoposide (2) and teniposide (3), as well as 
etopophos (4), a water-soluble prodrug of 2 (Stahelin and von Wartburg, 1989; Canetta et 
al., 1982; Joel 1996). These compounds are currently used as drugs, alone or in association, 
in clinical cancer chemotherapy against small cell lung cancer, acute leukemia, lymphoma, 
testicular carcinoma, and Kaposi’s sarcoma. Notably, these two structural modifications also 
led to a change in the mechanism of action. While PPT acts as antimicrotubule agent, 2 and 
3 function as topoisomerase II (topo II) inhibitors (Canela et al., 2000; Imbert, 1998). 
However, the therapeutic use of 2 and 3 is often hindered by problems such as acquired 
drug-resistance and poor water solubility (Liu et al., 2008). To get more potent analogs and 
to overcome drug-resistance, recently some nonsugar substituted analogs, particularly N-
linked congeners, exhibit superior pharmacological properties to etoposide, and 
consequently, several newer-generation clinical candidates, including NPF (5), GL-331 (6), 
and TOP-53 (7), have emerged through C-4 modification as alternatives to overcome the 
drawbacks of etoposide (Cragg and Newman, 2004; Lee, 1999; Liu et al., 1989). These 
successful examples imply that C-4 substitution plays an important role in the activity 
profiles of 1-analogs, and that optimization of this compound class through rational C-4 
modification is quite feasible. Both a composite pharmacophore model and comparative 
molecular field analysis also further demonstrated that the C-4 molecular area could 
accommodate considerable structural diversity (Cho et al., 1996).
Recently, the applications of click chemistry are increasingly interest in all aspects of drug 
discovery, ranging from initial lead identification through combinatorial chemistry and 
target-templated in situ chemistry, to proteonmics and DNA research, using bioconjugation 
reaction. The copper(I)-catalyzed 1,2,3-trizole formation from azides and terminal 
acetylenes is a particularly powerful linking reaction, in addition to be passive linkers, 1,2,3-
triazole ring is a widespread functional group in drugs (Kolb and Sharpless, 2003). 
Accordingly, it is intriguing to attach 1,2,3-triazoles to podophyllotoxin parent nucleus and 
has generated various potent aniline, phenol, thiophenol, and carbohydrate-based 1,2,3-
triazole derivatives, some of which exhibited significant antitumor activity (Bhat et al., 
2008; Reddy et al., 2008a, b; Chen et al., 2011, 2012). Additionally, a recent docking 
studies revealed that 1,2,3-triazole derivatives with various substituents in triazolemoiety 
showed better binding ability to topoisomerase II enzyme than etoposide (Reddy et al., 
2011). From this standpoint, logic-based design utilizing click chemistry could be 
advantageous.
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In our previous studies, we have introduced a stable nitroxyl radical into different positions 
in the PPT skeleton and proved that the resulting analogs can exhibit significant antitumor 
activity against several mouse transplantable tumors with remarkably decreased toxicity (Jin 
et al., 2006; Liu and Tian, 2005; Tian et al., 1997, 2002). Especially, GP-11 (8) is a typical 
example which has promise to be a new antitumor drug, GP-11 has been found which could 
increased the mitotic index and resulted in G2/M phase, and to a lesser extent, S arrest 
(Wang et al., 1993).
Inspired by the growing impact of click chemistry on drug discovery as well as our previous 
studies, we introduced the nitroxyl radical moiety into the molecule of podophyllotoxin at its 
C-4 via 1,2,3-triazol spacer as a part of our drug discovery program. Herein, a series of 
novel spin-labeled 4β-[(4-substituted)-1,2,3-triazol-1-yl] podophyllotoxin derivatives (17a–
h) were firstly designed, synthesized, and evaluated for their in vitro cytotoxic activity 
against four tumor cell lines (A-549, DU145, KB, and KBvin) (Fig. 1).
Results and discussion
Chemistry
As illustrated in Scheme 1, the starting materials, N-(1-oxyl-2,2,6,6-tetramethyl-4-
piperidinyl-oxycarbonyl) amino acids 14a–h, for the preparation of the target compounds 
17a–h were synthesized according to our previous procedure (Zhang et al., 2010; Liu et al., 
2012; Hankovszky et al., 1979). Briefly, 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl 10 
was prepared by catalytic oxidation of 4-hydroxy-2,2,6,6-tetramethylpiperidine 9 with 
sodium tungstate-hydrogen peroxide-EDTA in yield 85 %. Following, the reaction of 
compound 10 with N,N′-carbonyldiimidazol proceeds to give N-(1-oxyl-2,2,6,6-tetramethyl 
piperidinyloxycarbonyl)-imidazole 11 by the modified method. Compound 11, without 
further purification, was reacted with p-toluenesulfonic acid monohydrate to give its higher 
reactive tosylate 12. Compound 12 is instantaneously converted into alkoxycarbonyl azide 
13 when dissolved in an aqueous solution of sodium azide. Compounds 14a–h were 
obtained in good yield by reaction of 13 with free amino acids in presence of MgO. As 
illustrated in Scheme 2, 4β-Azido podophyllotoxin 15 was obtained in excellent yield by 
treating podophyllotoxin 1 with hydrazoic acid (HN3) in the presence of BF3·OEt2 (Tian et 
al., 1997). Compound 15 was allowed to react with propargyl alcohol in the presence of 
CuSO4·5H2O, sodium ascorbate in t-butyl alcohol, and water (1:2) at room temperature to 
selectively get 4β-[4-(4-methylol)-1,2,3-triazol-1-yl] podophyllotoxin 16. Compound 16 was 
then condensed with the appropriate nitroxide free radical 14a–h in the presence of 1,3-
diisopropylcarbodiimide (DIPC), 4-dimethylaminopyridine (DMAP) to provide the target 
compounds 17a–h in moderate yields. Synthesized target compounds 17a–h were 
characterized by melting point, ESR, IR, and HRMS spectral analyses.
Biology
Target compounds 17a–h were evaluated for in vitro cytotoxic activity against four different 
tumor cell lines, KB (nasopharyngeal), A-549 (lung), DU-145 (prostate), and KBvin (an 
MDR KB subline), using a sulforhodamine B colorimetric assay with triplicate experiments 
(Skehan et al., 1990). Etoposide was used as reference compound. The screening results are 
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shown in Table 1. Remarkably, compound 17h exhibited significant inhibitory activities 
against A549, DU-145, and KB with the IC50 value in the range of 5.49–5.6.30 μg/mL. 
Also, compound 17h displayed more potent cytotoxic activity against KBvin than etoposide 
(IC50>10 μg/mL). Surprisingly, all other compounds only displayed weak cytotoxicity 
against the four human tumor cell lines. However, the reason is not clear to our current 
knowledge and has to be subject of further investigations.
Experimental
General
Melting points were determined in Kofler apparatus and were uncorrected. IR spectra were 
measured on a Nicolet 5DX-FT-IR spectrometer on neat samples placed between KBr 
plates. Mass spectra were recorded on a Bruker Daltonics APEXII49e spectrometer with ESI 
source as ionization. The electron spin resonance (ESR) spectra were obtained from 10−3 M 
ethanol solution using a Bruker ER200D-SRC spectrometer. 1H NMR spectra were recorded 
at 400 MHz on a Bruker AM-400 spectrometer using TMS as reference (Bruker Company, 
USA). The N-(1-oxyl-2,2,6,6-tetramethyl-4-piperidinyloxycarbonyl)-amino acids 14a–h for 
the experiments were prepared by following a modified previous procedure as shown in 
Scheme 1 (Zhang et al., 2010; Liu et al., 2012; Hankovszky et al., 1979).
Synthesis of 4β-azido podophyllotoxin (15)—To a solution of Podophyllotoxin 1 (10 
g, 24 mmol) in appropriate, anhydrous dichloromethane was added hydrazoic acid (25 mL, 
C = 1.04 M, benzene) with stirring. BF3·Et2O (4.5 mL) was slowly drop into the mixture so 
as to keep temperature below −10 °C. Through TLC analysis, when most of the starting 
material had been consumed, pyridine (4.5 mL) and distilled water (80 mL) were added. The 
separated organic phase was washed successively by distilled water, 5 % hydrochloric acid, 
distilled water, 2 % sodium bicarbonate, distilled water, then dried over anhydrous sodium 
sulfate, and evaporated on rotary evaporator. The residue was recrystallized in acetone–
methanol to afford a white solid. Yield 75 %. mp: 110–112 °C; IR(KBr)ν/cm−1: 3430 
(NH2); 1 776 (Lactone); 1588, 1550, 1484 (aromatic C=C); 935 (OCH2O), 1H 
NMR(CDCl3) δ: 6.84 (s, 1H, H-5), 6.47 (s, 1H, H-8), 6.36 (s, 2H, H-2′, 6′), 5.97 (s, 2H, 
OCH2O), 4.58 (d, J = 5.1 Hz, 1H, H-1), 4.32 (m, 2H, H-11), 4.25 (d, J = 4.0 Hz, H-4), 3.80 
(s, 3H, 4′-OCH3), 3.75 (s, 6H, 3′,5′-OCH3), 3.32 (q, 1H, H-2), 2.92–2.63 (m, 1H, H-3), 1.83 
(d, 2H, 4-NH2).
Synthesis of 4β-[4-(4-methylol)-1,2,3-triazol-1-yl] podophyllotoxin (16)—A 
mixture of propargyl alcohol (30.6 mg, 0.55 mmol), CuSO4·5H2O (138 mg, 0.55 mmol), 
and sodium ascorbate (181 mg, 0.92 mmol) in t-butyl alcohol and water (1:2, 25 mL) was 
added 4β-azido podophyllotoxin 15 (200 mg, 0.46 mmol). The reaction mixture was stirred 
for 6 h at room temperature. After completion, the reaction mixture was diluted with 50 mL 
of water and extracted with chloroform (3 × 30 mL). The combined extracts were washed 
with saturated salt water, dried over anhydrous sodium sulfate, and evaporated on rotary 
evaporator. The residue was chromatographed on a silica gel column and eluted with ethyl 
acetate–petroleum ether to afford a white powder 80 mg, yield 35 %. mp: 160–162 °C; IR 
(KBr) cm−1: 3384, 2926, 1763, 1611, 1516, 1483, 1232, 1109, 1033, 997, 928; 1H NMR 
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(CDCl3) δ: 7.25 (s, 1H), 6.66 (s, 1H), 6.62 (s, 1H), 6.32 (s, 2H), 6.06 (d, J = 4.89 Hz, 1H), 
6.03 (s, 1H), 6.01 (s, 1H), 4.76 (d, J = 4.77 Hz, 1H), 4.42–4.39 (t, J = 6.79 Hz,1H), 3.77 (s, 
6H), 3.74 (s, 2H), 3.28–3.17 (m, 2H), 3.09–3.05 (dd, J = 8.57 Hz, 4.88 Hz, 1H); ESI–MS: 
482 [M +1].
General procedure of synthesis of 17a–h—Compound 16 (0.4 mmol) and 
appropriate nitroxide free radical 14a–h (0.48 mmol) were dissolved in appropriate 
anhydrous dichloromethane at room temperature, and to this solution, 1,3-
diisopropylcarbodiimide (DIPC 0.19 mL, 1.2 mmol) and 4-dimethylaminopyridine (DMAP 
97.6 mg, 0.8 mmol) were added at 0 °C and then warm to room temperature and left 
overnight. The product was washed with 0.1 M HCl (3 × 20 mL) and then washed with 
saturated salt water; the organic layer was dried over anhydrous sodium sulfate and 
evaporated on rotary evaporator. The residue was chromatographed on a silica gel column 
and eluted with ethyl acetate–petroleum ether to afford 17a–h.
4β-[{4-[N-(1-Oxyl-2,2,6,6-tetramethyl-4-piperidinyloxycarbonyl)-L-
glycinemethyl]}-1,2,3-triazol-1-yl] podophyllotoxin (17a): Yield: 55 %; red powder; mp: 
126–129 °C; IR (cm−1) 3370, 2973, 2939, 1778, 1713, 1420, 1361 (N–O·), 934; ESR: An = 
16.04G, g0 = 2.0061; HRMS (ESI) 773. 2866 for [M + Na]+ (calcd 773.2879 for 
C37H44O12N5).
4β-[{4-[N-(1-Oxyl-2,2,6,6-tetramethyl-4-piperidinyloxycarbonyl)-L-
alaninemethyl]}-1,2,3-triazol-1-yl] podophyllotoxin (17b): Yield: 62 %; red powder; mp: 
128–131 °C; IR (cm−1) 3343, 2975, 2939, 1779, 1711, 1422, 1360 (N–O·), 934; ESR: An = 
15.90G, g0 = 2.0060; HRMS (ESI) 787. 3063 for [M + Na]+ (calcd 787.3035 for 
C38H46O12N5).
4β-[{4-[N-(1-Oxyl-2,2,6,6-tetramethyl-4-piperidinyloxycarbonyl)-L-
prolinemethyl]}-1,2,3-triazol-1-yl] podophyllotoxin (17c): Yield: 60 %; red powder; mp: 
142–146 °C; IR (cm−1) 3343 2973, 2939, 1780, 1702, 1419, 1365 (N–O·), 929; ESR: An = 
16.12G, g0 = 2.0060; HRMS (ESI) 813. 3173 for [M + Na]+ (calcd 813.3192 for 
C40H48O12N5).
4β-[{4-[N-(1-Oxyl-2,2,6,6-tetramethyl-4-piperidinyloxycarbonyl)-L-
phenylalaninemethyl]}-1,2,3-triazol-1-yl] podophyllotoxin (17d): Yield: 56 %; red 
powder; mp: 127–131 °C; IR (cm−1) 3343, 2972, 2936, 1779, 1715, 1420, 1388 (N–O·), 
933; ESR: An = 16.12G, g0 = 2.0061; HRMS (ESI) 863. 3356 for [M + Na]+ (calcd 
863.3348 for C44H50O12N5).
4β-[{4-[N-(1-Oxyl-2,2,6,6-tetramethyl-4-piperidinyloxycarbonyl)-L-
methioninemethyl]}-1,2,3-triazol-1-yl] podophyllotoxin (17e): Yield: 55 %; red powder; 
mp: 115–119 °C; IR (cm−1) 3334, 2972, 2936, 1779, 1712, 1421, 1360 (N–O·), 935; ESR: 
An = 16.01G, g0 = 2.0060; HRMS (ESI) 847. 3081 for [M + Na]+ (calcd 847.3069 for 
C40H50O12SN5).
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isoleucinemethyl]}-1,2,3-triazol-1-yl] podophyllotoxin (17f): Yield: 55 %; red powder; 
mp: 121–126 °C; IR (cm−1) 3364, 2969, 2936, 1780, 1714, 1420, 1360 (N–O·), 934; ESR: 
An = 16.02G, g0 = 2.0060; HRMS (ESI) 829. 3525 for [M + Na]+ (calcd 829.3035 for 
C41H52O12N5).
4β-[{4-[N-(1-Oxyl-2,2,6,6-tetramethyl-4-piperidinyloxycarbonyl)-L-
tryptophanmetheyl]}-1,2,3-triazol-1-yl] podophyllotoxin (17g): Yield: 39 %; red powder; 
mp: 148–154 °C; IR (cm−1) 3354, 2971, 2936, 1777, 1714, 1507, 1422, 1361 (N–O·), 932; 
ESR: An = 16.28G, g0 = 2.0061; HRMS (ESI) 902.3442 for [M + Na]+ (calcd 902.3457 for 
C46H51O12N6).
4β-[{4-[N-(1-Oxyl-2,2,6,6-tetramethyl-4-piperidinyloxycarbonyl)-L-valine 
methyl]}-1,2,3-triazol-1-yl] podophyllotoxin (17h): Yield: 45 %; red powder; mp: 122–
125 °C; IR (cm−1) 3352, 2969, 2935, 1780, 1713, 1420, 1361 (N–O·), 934; ESR: An = 
16.04G, g0 = 2.0061; HRMS (ESI) 793. 3543 for [M + H]+ (calcd 793.3529 for 
C40H50O12N5).
Conclusion
In conclusion, a series of novel 4β-[(N-substituted)-1,2,3-triazol-1-yl] podophyllotoxin 
derivatives were synthesized by employing click chemistry protocol, and their structural 
information was extensively characterized by using IR, ESR, and HRMS. Also, their 
cytotoxic activity was evaluated against four tumor cell lines (A549, DU-145, KB, and 
KBvin) in vitro by using an SRB-assay. Especially, compound 17h displayed more potent 
cytotoxic activity against KBvin than etoposide. The cytotoxic results indicated that 
compound 17h may be a good lead for further structural modification.
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Structures of podophyllotoxin derivatives
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Synthesis of N-(1-oxyl-2,2,6,6-tetramethyl-4-piperidinyloxycarbonyl) amino acids 14a–h
Reagents and conditions: (i) Na2WO4/H2O2/EDTA; (ii) N,N′-carbonyldimidazole/THF; 
(iii) p-toluenesulfonic acid monohydrate; (iv) NaN3/water, stir; (v) amino acids/MgO, stir, 
24 h.
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Synthesis of target compounds 3a–f
Reagents and conditions: (i) HN3/BF3·Et2O, CH2Cl2; (ii) Propargyl alcohol, 
CuSO4,Sodium ascorbate, H2O: t-BuOH=2:1; (iii) DIPC/DMAP, dry CH2Cl2
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Table 1
In vitro cytotoxic assay against four tumor cell lines
Entry IC50 (μg/mL)
A549 DU-145 KB KBvin
17a >10 >10 >10 >10
17b >10 >10 >10 >10
17c >10 >10 >10 >10
17d >10 >10 >10 >10
17e >10 >10 >10 >10
17f >10 >10 >10 >10
17g >10 >10 >10 >10
17h 5.91 ± 0.53 5.49 ± 0.42 5.71 ± 0.11 6.30 ± 0.41
Etoposide 1.51 ± 0.25 1.19 ± 0.12 2.28 ± 0.19 >10
Med Chem Res. Author manuscript; available in PMC 2015 November 01.
